Commission on Cancer- Accredited Community Cancer Program with Commendation
The Commission on Cancer (CoC) of the American College of Surgeons (ACoS) has granted three-year accreditation with commendation to Mount Sinai Hospital’s Cancer Program.A facility receives a three-year accreditation with commendation following an on-site evaluation by a physician surveyor during which the facility demonstrates commendable compliance with one or more standards that represent the full scope of the cancer program. This includes cancer committee leadership, cancer data management, clinical services, research, community outreach, and quality improvement. Three-year accreditation with commendation is given to programs that receive a commendation rating for one or more standards and have no deficiencies.Receiving care at a Commission on Cancer-accredited cancer program or hospital ensures high-quality, comprehensive care from teams of specialists who can coordinate the best treatment options available for you.There are currently more than 1,500 Commission on Cancer-accredited cancer programs in the U.S. and Puerto Rico, representing 30% of all hospitals. Mount Sinai Hospital’s Cancer Program is proud to be a part of that 30 percent
Clinical trials are studies in which people volunteer to take part in tests of new drugs or procedures. Doctors use clinical trials to develop new treatments for serious diseases such as cancer. Mount Sinai’s Cancer Program actively participates in clinical trials and research. In 2014, Mount Sinai Hospital’s Cancer Program was awarded the prestigious Clinical Trials Participation Award from the Conquer Cancer Foundation, a research affiliation of the American Society of Clinical Oncology. Dr. Pam Khosla, Medical Director of Hematology/Oncology, accepted the award on behalf of Mount Sinai Hospital’s Cancer Program. During that year, Mount Sinai Hospital’s Cancer Program enrolled 63 oncology patients in clinical trials, approximately 14% of the new oncology patients seen. The Commission on Cancer standard requires that all accredited Cancer Programs participate in cancer research. The Conquer Cancer Foundation of the American Society of Clinical Oncology takes great pride in its awards and grants programs and in the individuals and organizations selected each year to receive these honors. The award and grant recipients are dedicated to improving the care of people living with cancer and are making great contributions to advancing cancer research. Mount Sinai Hospital’s Cancer Program is dedicated to making lives betterfor people living with cancer and proud to participate in the eradication of cancer!
The American Society of Clinical Oncology’s Quality Oncology Practice Initiative (QOPI)
The American Society of Clinical Oncology’s Quality Oncology Practice Initiative (QOPI) is a voluntary program dedicated to ensuring high-quality cancer care. QOPI is designed to measure care provided in outpatient oncology practices and centers. Studies have shown that high-quality cancer care can result in avoidable morbidities and mortalities, and are cost-effective. Findings from the 107 assessment metrics demonstrate that our Oncologists are consistently performing at high levels in many core areas of care and are quickly incorporating new standard tests and treatments into everyday practice, as compared to the aggregate across the nation. The quality data from the 2014 QOPI Audit was so impressive, that our Mount Sinai Hospital’s Cancer Program was awarded a Certificate of Excellence from the QOPI Certification Program. Mount Sinai Hospital’s Cancer Program is one of only 34 QOPI-certified Oncology practices in the State of Illinois. Mount Sinai Hospital is proud to bear the distinction of being a QOPI certified cancer treatment program.